<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Nash | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/saletire0/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/saletire0/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Nash.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">a66fdd6c56c5f81c1c940b74e74012cf</guid>
				<title>Nash posted an update: Mycotic or fungal keratitis (FK) is a sight-threatening [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35108/</link>
				<pubDate>Sat, 01 Feb 2025 08:00:42 -0800</pubDate>

									<content:encoded><![CDATA[<p>Mycotic or fungal keratitis (FK) is a sight-threatening disease, caused by infection of the cornea by filamentous fungi or yeasts. In tropical, low and middle-income countries, it accounts for the majority of cases of microbial keratitis (MK). Filamentous fungi, in particular Fusarium spp., the aspergilli and dematiaceous fungi, are responsible&hellip;<span class="activity-read-more" id="activity-read-more-35108"><a href="http://www.nationalboardinstitute.com/activity/p/35108/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f922530a8b6c660ae0042b3fc088d04e</guid>
				<title>Nash posted an update: 2%) was obtained for non-neurological purposes. An [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33154/</link>
				<pubDate>Thu, 30 Jan 2025 08:04:58 -0800</pubDate>

									<content:encoded><![CDATA[<p>2%) was obtained for non-neurological purposes. An additional 3,793 claims (8.4%) wherein the test ordered could not be clearly identified were associated with a neurology-related ICD-9 CCS. Conclusions Accurate assessment of genetic testing utilization using claims data is not possible given the high prevalence of nonspecific codes. Reducing the&hellip;<span class="activity-read-more" id="activity-read-more-33154"><a href="http://www.nationalboardinstitute.com/activity/p/33154/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">412fef92e74cd4e68e90801fbfe088fc</guid>
				<title>Nash became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/32772/</link>
				<pubDate>Tue, 28 Jan 2025 19:46:08 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>